Postpartum Hemorrhage (PPH): Clinical Causes, Risk Factors, Recognition, and Evidence-Based Management to Prevent Maternal Death

By | June 13, 2026

Postpartum hemorrhage (PPH) refers to excessive bleeding after childbirth and is among the most urgent, life-threatening obstetric emergencies worldwide. Clinically, PPH is commonly defined as blood loss of at least 500 mL following vaginal birth or at least 1,000 mL after cesarean delivery, or any amount of blood loss that causes hemodynamic instability. Because hemorrhage can progress rapidly to shock, timely recognition and immediate intervention are decisive for survival.

A core mechanistic framework for PPH prevention and treatment is the “four Ts”: Tone, Trauma, Tissue, and Thrombin. These categories reflect the dominant physiologic pathways by which bleeding occurs.

1) Tone (most common): Uterine atony, or failure of the uterus to contract effectively after delivery, is the leading cause of PPH. Normally, uterine contractions compress spiral arteries and minimize blood loss. When the uterus remains relaxed—due to uterine overdistension (multiple gestations, polyhydramnios), prolonged labor, or induction/augmentation complications—bleeding accelerates. Additional contributors include chorioamnionitis and anemia-related reduced physiologic reserve.

2) Trauma: Genital tract lacerations (cervical, vaginal, perineal) and uterine rupture can produce major bleeding. Risk increases with operative vaginal delivery, macrosomia, malpresentation, and inadequate repair of tears. Even subtle injury can cause ongoing bleeding if not identified.

3) Tissue: Retained placental tissue prevents complete uterine involution. Incomplete separation of the placenta or abnormal placentation (e.g., placenta accreta spectrum) can lead to persistent hemorrhage. Infection can further impair uterine contraction.

4) Thrombin: Coagulopathies, whether pre-existing (e.g., von Willebrand disease) or acquired (e.g., disseminated intravascular coagulation in severe obstetric complications), affect clot formation. Conditions such as severe preeclampsia/HELLP syndrome, massive abruption, and sepsis may precipitate thrombostatic failure, resulting in diffuse, uncontrolled bleeding.

Risk factors span maternal, obstetric, and health-system dimensions. Maternal factors include previous PPH, anemia, advanced maternal age, and multiparity. Obstetric factors include prolonged or obstructed labor, operative delivery, multiple gestations, polyhydramnios, placental abnormalities, and induction with uterotonics. Health-system issues—delayed referral, limited blood supply, and restricted availability of uterotonics, uterine balloon tamponade, or operating theatre time—strongly influence outcomes.

Recognition is clinical and time-sensitive. Vital signs may initially be preserved, especially in young, otherwise healthy patients, but progressive tachycardia, hypotension, pallor, altered mental status, and dizziness signal shock. Quantification of blood loss is recommended where feasible. Examination should assess uterine tone (boggy uterus suggests atony), inspect for lacerations, and evaluate for retained products. If coagulopathy is suspected, clinicians should consider the severity of underlying disease.

Evidence-based management proceeds in a “stepwise escalation” manner. First-line therapy is uterine massage and uterotonic medication. Oxytocin is the standard first uterotonic, given promptly after delivery to prevent atony and to treat established PPH. If bleeding continues, additional uterotonics such as tranexamic acid and other agents (e.g., ergometrine where appropriate, and prostaglandin analogues depending on contraindications) are used according to protocols. Tranexamic acid, an antifibrinolytic, reduces bleeding by inhibiting plasmin formation; it is most effective when administered early in hemorrhage.

Simultaneously, clinicians should address the cause: repair lacerations, manually remove retained tissue if indicated and trained for the situation, and evaluate for uterine rupture or abnormal placentation. For refractory atony, uterine balloon tamponade can rapidly control bleeding while preparing escalation to surgical options. Surgical management may include uterine artery ligation, B-Lynch suturing, or hysterectomy as a life-saving measure when conservative strategies fail.

Resuscitation is integral. Large-bore intravenous access, monitoring of urine output, and rapid correction of hypovolemia are essential. Blood transfusion thresholds depend on ongoing bleeding, hemodynamics, and laboratory parameters where available. Modern PPH care emphasizes multidisciplinary hemorrhage bundles, which coordinate medication administration, transfusion, and procedural readiness to reduce delays.

Prevention combines risk stratification and proactive care. Active management of the third stage of labor, oxytocin availability, management of anemia during pregnancy, skilled birth attendance, and timely referral for high-risk cases decrease incidence and severity. Community awareness and preparedness—including encouraging blood donation—can mitigate mortality when severe hemorrhage occurs and transfusion is required urgently.

Source: @MinofHealthUG (Ministry of Health Uganda)

News Source

SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.

SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.

Leave a Reply

Your email address will not be published. Required fields are marked *